Navigation Links
biocatalysis in Medical News

Synthetech Announces Fiscal 2009 Results

... these projects. About Synthetech Synthetech, Inc., based in Albany, Oregon, is a fine chemicals company specializing in organic synthesis, biocatalysis and chiral technologies. We develop and manufacture amino acid derivatives, specialty amino acids, peptide fragments and proprietary custom chiral in...

Synthetech Earns National Recognition for Performance Improvement Program

...rinciples. To learn more visit http://www.chemstewards.com . Synthetech, Inc. is a fine chemicals company specializing in organic synthesis, biocatalysis and chiral technologies. Synthetech develops and manufactures amino acid derivatives, specialty amino acids, peptide fragments, proprietary custom chi...

Synthetech Reports Second Quarter Fiscal 2009 Results

...tial of these projects. About Synthetech Synthetech, Inc., based in Albany, Oregon, is a fine chemicals company specializing in organic synthesis, biocatalysis and chiral technologies. We develop and manufacture amino acid derivatives, specialty amino acids, peptide fragments, proprietary custom chiral interm...

Synthetech Announces Appointment of Dr. Gregory R. Hahn as President and Chief Executive Officer

... and dedicated service to Synthetech as its CEO." About Synthetech Synthetech, Inc. is a fine chemicals company specializing in organic synthesis, biocatalysis and chiral technologies. Synthetech develops and manufactures amino acid derivatives, specialty amino acids, peptide fragments, proprietary custom chi...

Heparin Based Nanoscale Materials Developed For Dialysis Treatment

... are blood compatible.’ The research team is led by Robert Linhardt, the Ann and John H. Broadbent Jr. '59 Senior Constellation Professor of biocatalysis and Metabolic Engineering at Rensselaer, and includes collaboration with Pulickel Ajayan, the Henry Burlage Professor of Materials Science and Eng...
biocatalysis in Medical Technology

DSM and LibraGen Sign Agreement to Co-Develop Transaminases for Production of Chiral Amines

...hiral amines," said Oliver May, Competence Manager biocatalysis at DSM Pharmaceutical Products. "In addition, by c...orward in the development of LibraGen's industrial biocatalysis capabilities. Customers of DSM and LibraGen will b...novative bioprocesses for molecule synthesis using biocatalysis for fine chemicals, cosmetics and pharmaceutical i...
biocatalysis in Biological News

University of Minnesota research leads to new technology to protect human health

...ection of melamine contamination in the global food supply." Research to develop the enzyme for the melamine test was supported by the University's biocatalysis Initiative. "This is an example of how a small but strategic investment in scientific research can make a big difference," says Robert P. Elde, de...

Rensselaer receives more than $2 million from New York State to fund stem cell research

...n the human body. The lead researchers for the grants are Robert Linhardt, the Ann and John H. Broadbent Jr. '59 Senior Constellation Professor of biocatalysis and Metabolic Engineering, and Russell Ferland, assistant professor of biology. "This funding announcement couldn't come at a more exciting time in...

Researchers create safer alternative to heparin

...d what was believed to be contaminated batches of heparin. Linhardt, who is the Ann and John H. Broadbent Jr. '59 Senior Constellation Professor of biocatalysis and Metabolic Engineering at Rensselaer Polytechnic Institute, was on the international team that identified the suspected contaminant in the Chinese ...

Undergrad has sweet success with invention of artificial Golgi

... decades more experience to creating an artificial Golgi, said Robert Linhardt, the Ann and John H. Broadbent Jr. 59 Senior Constellation Professor of biocatalysis and Metabolic Engineering at Rensselaer and Martins adviser. He saw a problem in the drug discovery process and almost instantly devised a way to solv...

Deadly dose: Rensselaer heparin expert helps uncover source of lethal contamination

...ecessary to determine the source of the contamination. Robert J. Linhardt, the Ann and John H. Broadbent Jr. '59 Senior Constellation Professor of biocatalysis and Metabolic Engineering at Rensselaer, is part of an international team that recently announced it had uncovered the source of the deadly contaminat...

Beyond batteries: Storing power in a sheet of paper

...f paper, but its made in a very intelligent way, said paper co-author Robert Linhardt, the Ann and John H. Broadbent Senior Constellation Professor of biocatalysis and Metabolic Engineering at Rensselaer. Were not putting pieces together its a single, integrated device, he said. The components are molecularl...

Blood-compatible nanoscale materials possible using heparin

...s that are blood compatible." The research team is led by Robert Linhardt, the Ann and John H. Broadbent Jr. '59 Senior Constellation Professor of biocatalysis and Metabolic Engineering at Rensselaer, and includes collaboration with Pulickel Ajayan, the Henry Burlage Professor of Materials Science and Enginee...

Heparin prepared synthetically could replace animal-derived drug

...ering recently discovered heparin biosynthetic enzymes," says Robert Linhardt, the Ann and John H. Broadbent Jr. '59 Senior Constellation Professor of biocatalysis and Metabolic Engineering at Rensselaer Polytechnic Institute. "These discoveries will enable us to effectively replace a variable raw material ?hepar...

Rensselaer researchers develop approach that predicts protein separation behavior

...the intersection of the life sciences and engineering to encourage discovery and innovation. Rensselaer's four biotechnology research constellations - biocatalysis and metabolic engineering, functional tissue engineering and regenerative medicine, biocomputation and bioinformatics, and integrative systems biology...
biocatalysis in Biological Technology

Synthetech Reports First Quarter Fiscal 2010 Results

...hese projects. About Synthetech Synthetech, Inc., based in Albany, Oregon, is a fine chemicals company specializing in organic synthesis, biocatalysis and chiral technologies. We develop and manufacture amino acid derivatives, specialty amino acids, peptide fragments and proprietary custom chiral in...

Codexis R&D Productivity Panels Also Used By Roche

...y have been used by more than 10 pharmaceutical companies worldwide. "We are very pleased that Roche, a world leading company, will use Codexis biocatalysis technology to enhance pharmaceutical process manufacturing productivity," said Peter Seufer-Wasserthal, Ph.D., Senior Vice President, Codexis Pharmace...

BASF Set To Commercialize pro-t-action(TM) Eliminating Caries Causing Bacteria From the Mouth

... research and advancement in white biotechnology otherwise known as industrial biotechnology. In white biotechnology, BASF combines broad expertise in biocatalysis and fermentation technology with core competencies in chemistry, process know-how and application technology to create novel solutions for customers. ...

Codexis Names Lori Giver VP Systems Biology

...odexis technology platform has been invaluable," Dr. Anton said. "She is one of the original core team of scientists that built both our expertise in biocatalysis and our world-class reputation in this field. Her appointment recognizes the role that systems biology, in combination with biocatalysis, will play i...

Synthetech Announces New Director of Manufacturing

...e short- and long-term challenges at Synthetech." About Synthetech Synthetech, Inc. is a fine chemicals company specializing in organic synthesis, biocatalysis and chiral technologies. Synthetech develops and manufactures amino acid derivatives, specialty amino acids, peptide fragments, proprietary custom chi...

Codexis, Arch Announce Expanded Collaboration

... REDWOOD CITY, Calif. and MUMBAI, India, Aug. 25 /PRNewswire/ -- Codexis, Inc., a leader in biocatalysis technology, and Arch Pharmalabs Limited, a leading Indian active pharmaceutical ingredients (APIs) and intermediates manufacturer, today announced a m...

CBDM.T, The Market and Business Intelligence Company Reviews The Enzyme Market

...r oil-based chemistry substitution. Enzymes are a key element in performing biocatalysis (biocatalysts are in fact enzymes). This means that biocatalysis will probably be a significant segment in the future enzyme market. This pr...

Synthetech Announces Fiscal 2008 Results

..., timing and revenue potential of these projects. About Synthetech Synthetech, Inc. is a fine chemicals company specializing in organic synthesis, biocatalysis and chiral technologies. Synthetech develops and manufactures amino acid derivatives, specialty amino acids, peptide fragments, proprietary custom chi...

Synthetech Earns National Recognition for Performance Improvement Program

... Core Principles. To learn more visit http://www.chemstewards.com . Synthetech, Inc. is a fine chemicals company specializing in organic synthesis, biocatalysis and chiral technologies. Synthetech develops and manufactures amino acid derivatives, specialty amino acids, peptide fragments, proprietary custom chi...
Other Tags
(Date:8/22/2014)... (PRWEB) August 22, 2014 According ... Type & Application - Global Trends & Forecast ... with an analysis and forecast of the market ... to $38,729 million by 2019, at a significant ... market data tables and 44 figures spread through ...
(Date:8/22/2014)... Hallandale Beach, Florida (PRWEB) August 22, 2014 ... treatment for Lasik in Fort Lauderdale at the most ... patients get better eyesight through their advanced Lasik treatments. ... available worldwide and the Braverman Eye Center has been ... thousands of patients live a glasses-free and contact lenses-free ...
(Date:8/22/2014)... a wide range of epigenetic changesalterations in DNA across the ... with Crohn,s disease (CD), reports Inflammatory Bowel Diseases ... Foundation of America (CCFA). The journal is published ... Wolters Kluwer Health . , The study ... of the genome in children with CD, according to Professor ...
(Date:8/22/2014)... confused with lactose intolerance. However, these are two entirely ... lactose intolerance do not digest lactose properly because they ... of the potentially much more dangerous cow milk allergy, ... its own IgE antibodies. , According to statistics, about ... from a genuine milk allergy. Less adults are diagnosed ...
(Date:8/22/2014)... Medical Oncology (ESMO), the leading pan-European organisation representing ... three outstanding individuals receiving the Society,s esteemed annual ... Bokemeyer, Heikki Joensuu and Peter Boyle on the ... Madrid, Spain. , Carsten Bokemeyer will receive the ... transition of cancer discovery into real benefit at ...
Breaking Medicine News(10 mins):Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 2Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 3Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 4Health News:Braverman Eye Center Now Offers Lasik Treatment in Fort Lauderdale at the Most Affordable Fee 2Health News:Study shows epigenetic changes in children with Crohn's disease 2Health News:Scientists uncover why major cow milk allergen is actually allergenic 2Health News:ESMO honours outstanding oncology professionals 2Health News:ESMO honours outstanding oncology professionals 3
(Date:8/21/2014)... of the water window? It consists of radiations in ... absorbed by the water in biological tissues. New theoretical ... radiations within the water window. These could be the ... image of the biological samples or to be used ... the physical mechanism needed to efficiently generate the harmonic ...
(Date:8/21/2014)... University (ANU) team has successfully replicated one of the ... systems powered by sunlight which could manufacture hydrogen as ... sunlight. It is an exciting prospect to use them ... said Dr Kastoori Hingorani, from the ARC Centre of ... of Biology. , Hydrogen offers potential as a zero-carbon ...
(Date:8/20/2014)... Institute (HCI) at the University of Utah have identified ... BCR-ABL, the unregulated enzyme driving the blood cancer chronic ... nearly 6,000 new cases of CML will be diagnosed ... kinase inhibitors (TKIs), target BCR-ABL and are effective at ... control it in a way that allows patients to ...
Breaking Biology News(10 mins):Water window imaging opportunity 2Water and sunlight the formula for sustainable fuel 2Blueprint for next generation of chronic myeloid leukemia treatment 2
Other Contents